2082 Organometallics, Vol. 19, No. 11, 2000
Paisner et al.
13C{1H} NMR: δ 10.5, 19.1 (d, J C-P ) 37 Hz), 94.5, 123.2,
128.7, 132.4, 148.7, 158.4. 31P{1H} NMR: δ -37.9. Anal. Calcd
for C20H29IrNO3P: C, 43.31; H, 5.27. Found: C, 43.56; H, 5.55.
Cp *(P Me3)Ir [C(O)-p-CF 3C6H4]H (3e). Complex 1 (72.2
mg, 0.191 mmol), 2e (47.1 mg, 0.225 mmol), and 7 (59.8 mg,
0.279 mmol) were dissolved in benzene (6 mL). Stirring for 48
h and workup as above resulted in the formation of 72.2 mg
(65%) of 3e as yellow crystals. IR (C6H6): 3058, 2905, 2096,
) 36 Hz), 1.19 (d, 9 H, J P-H ) 5 Hz), 1.274 (s, 9 H), 1.82 (d, 15
H, J P-H ) 2 Hz). 13C{1H} NMR: δ 11.2, 19.8 (d, J C-P ) 37
Hz), 29.9, 57.1, 94.4, 248.0. 31P{1H} NMR: δ 39.46 ppm. Anal.
Calcd for C18H34IrOP: C, 44.15; H, 7.00. Found: C, 44.17; H,
7.40.
Cp *(P Me3)Ir (Cl)(CHCH2) (15a ). Complex 1 (99.3 mg,
0.245 mmol), 2k (22.1 mg, 0.281 mmol), and 7 (62.3 mg, 0.291
mmol) were dissolved in benzene (6 mL). Upon stirring for 18
h the solvent was removed in vacuo to give a yellow oil. The
yellow oil was dissolved in pentane (10 mL) and filtered
through SiO2 (100 mg). Removal of the solvent in vacuo
afforded a yellow powder, which was recrystallized from
pentane. This resulted in the formation of 69.6 mg (61%) of
15a as yellow crystals. IR: 2903, 2099, 1603, 1573, 1555, 1455,
1564, 1482, 1322, 1124, 1002, 980, 860, 720, 490 cm-1
.
1H
NMR: δ -16.35 (d, 1 H, J P-H ) 36 Hz), 1.25 (d, 6 H, J P-H
)
10 Hz), 1.67 (s, 15 H, J P-H ) 1 Hz), 7.52 (d, 1 H, J H-H ) 8 Hz),
8.08 (d, 1 H, J H-H ) 8 Hz). 13C{1H} NMR: δ 9.9, 18.4 (d, J C-P
) 37 Hz), 93.7, 113.5, 124.2, 124.5, 127.5, 128.8, 131.1. 31P-
{1H} NMR: δ -37.8. 19F{1H} NMR: δ -61.8. Anal. Calcd for
C
21H29IrOPF3: C, 43.67; H, 5.06. Found: C, 43.71; H, 5.28.
1414, 1278, 1144 cm-1 1H NMR: δ 1.19 (d, 9 H, J P-H ) 11
.
Hz), 1.48 (d, 15 H, J P-H ) 2 Hz), 5.36 (ddd, 1 H, J H-H ) 15
Hz, J H-H ) 10 Hz, J H-P ) 2 Hz), 6.68 (ddd, J H-H ) 15 Hz,
Cp *(P Me3)Ir [C(O)-p-F C6H4]H (3f). Complex 1 (93.1 mg,
0.247 mmol), 2f (45.3 mg, 0.286 mmol), and 7 (58.4 mg, 0.273
mmol) were dissolved in benzene (6 mL). Stirring for 72 h and
workup as above resulted in the formation of 69.8 mg (54%)
of 3f as yellow crystals. IR (C6H6): 3117 (s), 3058 (s), 2902
(w), 2101 (w), 1822 (d), 1594 (s), 1561 (s), 1488 (s), 1095, 987,
J H-H ) 10 Hz, J H-P ) 2 Hz), 9.11 (ddd, J H-H ) 15 Hz, J H-H
)
10 Hz, J H-P ) 1 Hz). 13C{1H} NMR: δ 9.3, 13.9 (d, J C-P ) 37
Hz), 92.6, 118.4, 145.4. 31P{1H} NMR: δ -30.8. Anal. Calcd
for C15H27ClIrP: C, 38.66; H, 5.84. Found: C, 38.82; H, 6.09.
Cp *(P Me3)Ir (Cl)(CHCHCH3) (15b). Complex 1 (80.6 mg,
0.199 mmol), 2l (23.4 mg, 0.253 mmol), and 7 (46.5 mg, 0.217
mmol) were dissolved in benzene (5 mL). Stirring for 18 h and
workup as above resulted in the formation of 44.9 mg (47%)
of rotational isomers of 15b as yellow crystals (major:minor,
4:1). IR (both isomers): 2959, 2914, 2844, 1584, 1446, 1377,
1
964, 896, 653, 627, 598, 483 (s) cm-1. H NMR: δ -16.36 (d,
1 H, J P-H ) 36 Hz), 1.22 (d, 9 H, J P-H ) 11 Hz), 1.74 (s, 15 H,
J P-H ) 1 Hz), 6.92 (t, 2 H, J H-H ) 17 Hz), 8.17 (t, 2 H, J H-H
)
14 Hz). 13C{1H} NMR: δ 10.0, 18.4 (d, J C-P ) 37 Hz), 93.5,
113.5, 127.5, 128.0, 129.5, 131.1. 31P{1H} NMR: δ -37.8. 19F-
{1H} NMR: δ -113. Anal. Calcd for C20H29IrOPF: C, 45.53;
H, 5.54. Found: C, 45.20; H, 5.74.
1278, 1210, 1152, 1073, 1209, 957, 855, 734, 681, 616 cm-1
.
1H NMR major isomer: δ 1.19 (d, 9 H, J P-H ) 11 Hz), 1.49 (d,
15 H, J P-H ) 2 Hz), 2.06 (d, 3 H, J H-H ) 6 Hz), 5.43 (m, 1 H),
8.25 (d, 1 H, J H-H ) 12 Hz); minor isomer: δ 1.25 (d, 9 H,
J P-H ) 11 Hz), 1.51 (d, 15 H, J P-H ) 2 Hz), 1.75 (d, 3 H, J H-H
) 5 Hz), 6.81 (m, 1 H), 8.35 (m, 1 H). 13C{1H} NMR δ major
and minor isomers: 9.3, 9.5, 14.0 (d, J C-P ) 37 Hz), 14.3 (d,
J C-P ) 37 Hz), 25.39, 25.40 92.40, 92.53, 126.6, 132.8 ppm.
31P{1H} NMR major isomer: δ -30.7; minor isomer: δ -34.6
ppm. Anal. Calcd for C11H29IrPCl: C, 40.03; H, 6.09. Found:
C, 39.93; H, 6.22.
Cp *(P Me3)Ir [C(O)-p-OCH3 C6H4]H (3g). Complex 1 (72.3
mg, 0.192 mmol), 2g (34.9 mg, 0.205 mmol), and 7 (44.9 mg,
0.210 mmol) were dissolved in benzene (6 mL). Stirring for 5
days and workup as above resulted in the formation of 72.3
mg (70%) of 3g as yellow crystals. IR (C6H6): 2977, 2901, 2101,
1829, 1581, 1552, 1522, 1495, 1182, 1002, 879, 728, 708, 654,
598, 476 cm-1. 1H NMR: δ -16.29 (d, 1 H, J P-H )36 Hz), 1.27
(d, 9 H, J P-H ) 10 Hz), 1.82 (s, 15 H, J P-H ) 2 Hz), 3.30 (s, 3
H), 6.37 (d, 2 H, J H-H ) 9 Hz), 7.85 (d, 2 H, J H-H ) 9 Hz).
13C{1H} NMR: δ 10.7, 19.2 (d, J C-P ) 37 Hz), 55.1, 94.2, 112.8,
128.7, 131.8, 148.0, 161.9. 31P{1H} NMR: δ -37.7. Anal. Calcd
for C21H32IrO2P: C, 46.74; H, 5.98. Found: C, 47.13; H, 6.23.
Cp *(P Me3)Ir [C(O)CHMe2]H (4). Complex 1 (80.9 mg,
0.199 mmol), 2h (19.8 mg, 0.186 mmol), and 7 (45.7 mg, 0.213
mmol) were dissolved in benzene (6 mL). Stirring for 48 h and
workup as above resulted in the formation of 52.5 mg (59%)
of 4 as yellow crystals. Compounds 4 decomposed at ambient
temperature over 24 h. IR (KBr): 2959, 2909, 2857, 2093, 1591,
1459, 1419, 1378, 1277, 1069, 1029, 959, 927, 841, 769, 728,
Cp *(P Me3)Ir (Cl)(CHCHC6H5) (15c). Complex 1 (89.0 mg,
0.219 mmol), 2m (44.1 mg, 0.285 mmol), and 7 (51.7 mg, 0.241
mmol) were dissolved in benzene (7 mL). Stirring for 18 h and
workup as above resulted in the formation of 77.1 mg (65%)
of 15c as yellow crystals. IR: 2959, 2917, 1594, 1579, 1552,
1483, 1441, 1373, 1278, 1168, 1071, 1028, 973, 953, 849, 814,
1
746, 733, 695, 677, 610, 543, 502, 467 cm-1. H NMR: δ 1.14
(d, 9 H, J P-H ) 11 Hz), 1.49 (d, 15 H, J P-H ) 2 Hz), 6.63 (dd,
1 H, J H-H ) 17 Hz, J P-H ) 3 Hz), 7.04 (t, 1 H, J H-H ) 7 Hz),
7.23 (t, 2 H, J H-H ) 7.5 Hz), 7.46 (d, 2H, J H-H ) 7 Hz), 9.63
(dd, 1 H, J H-H ) 17 Hz, J P-H ) 2 Hz). 13C{1H} NMR (C6D6):
δ 9.3, 14.1 (d, J C-P ) 37 Hz), 92.9, 125.2, 125.4, 129.1, 134.7,
139.6, 143.7. 31P{1H} NMR (C6D6): δ -30.17. Anal. Calcd for
1
679, 637 cm-1. H NMR: δ -17.0 (d, 1 H, J P-H ) 36 Hz), 1.17
(d, 3 H, J H-H ) 7 Hz), 1.21 (d, 9 H, J P-H ) 10 Hz), 1.25 (d, 3
H, J H-H ) 7 Hz), 1.85 (d, 15 H, J P-H ) 2 Hz), 3.00 (m, 1 H).
13C{1H} NMR: δ 10.9, 19.2 (d, J C-P ) 37 Hz), 19.5, 19.8, 64.9,
94.6, 226.6. 31P{1H} NMR: δ -39.4. FAB ES MS Calcd for
C
16H31PIrCl: C, 46.53; H, 5.76. Found: C, 46.21; H, 6.12.
C
17H32OP193Ir+7Li: 481.1962. Found: 481.1957.
Cp *(P P h Me2)Ir Cl2 (28). To a red/orange solution of
Cp *(P Me3)Ir [C(O)CHP h 2]H (5). Complex 1 (99.0 mg,
[Cp*IrCl2]2 (1.01 g, 1.26 mmol) in CH2Cl2 (75 mL, sparged with
N2) was added P(C6H5)(CH3)2 (0.21 mL, 1.47 mmol) via syringe
to give a bright orange solution. After stirring for 18 h, the
solvent was removed in vacuo to give an orange powder. This
powder was passed through a SiO2 column with Et2O/CH2Cl2
(3:1) as the eluent. The solvent was removed in vacuo to give
1.13 g (83%) of the product as an orange powder. IR: 2983,
2914, 1434, 1106, 1034, 951, 912, 847, 760, 720, 701, 492, 438
0.244 mmol), 2i (56.8 mg, 0.246 mmol), and 7 (54.2 mg, 0.253
mmol) were dissolved in benzene (5 mL). Stirring for 24 h and
workup as above resulted in the formation of 99.1 mg (68%)
of 5 as yellow crystals. IR: 2096, 1602, 1498, 1447, 1419, 1203,
1
1169, 1084, 1030, 939, 852, 797, 730, 703, 678, 607 cm-1. H
NMR: δ -16.7 (d, 1 H, J P-H ) 36 Hz), 1.07 (d, 9 H, J P-H ) 10
Hz), 1.70 (d, 15 H, J P-H ) 2 Hz), 5.95 (s, 1 H). 13C{1H} NMR:
δ 10.8, 20.7 (d, J C-P ) 37 Hz), 90.4, 93.6, 125.5, 125.8, 128.9,
129.4, 142.3. 31P{1H} NMR (C6D6): δ -39.75. Anal. Calcd for
23H36PIrO: C, 54.16; H, 5.89. Found: C, 53.93; H, 6.23.
Cp *(P Me3)Ir [C(O)-ter t-C4H9]H (6). Complex 1 (101 mg,
0.248 mmol), 2j (35.9 mg, 0.297 mmol), and 7 (65.4 mg, 0.305
mmol) were dissolved in benzene (6 mL). Stirring for 18 h and
workup as above resulted in the formation of 61.3 mg (51%)
of 6 as yellow crystals. IR: 2975, 2943, 2902, 2085, 1573, 1479,
1453, 1418, 1375, 1349, 1280, 1027, 955, 938, 888, 855, 800,
762, 728, 681, 668, 612 cm-1. 1H NMR: δ -17.00 (d, 1 H, J P-H
1
cm-1. H NMR (CD2Cl2): δ 1.42 (d, 15 H, J P-H ) 2 Hz), 1.86
(d, 6 H, J P-H ) 11 Hz), 7.44 (m, 3 H; meta and para positions
are overlapped), 7.65 (m, 2 H). 13C{1H} NMR (C6D6): δ 8.6,
12.86 (d, J C-P ) 40 Hz), 91.3, 130.5, 131.0, 131.6, 131.7. 31P-
{1H} NMR (C6D6): δ -19.66. Anal. Calcd for C13H26PIrCl2: C,
40.30; H, 4.88. Found: C, 40.42; H, 5.17.
Cp *(P P h Me2)Ir H2 (1c). Cp*PhMe2IrCl2 (1.02 g, 1.80 mmol)
was treated with Zn powder (3.20 g, 48.9 mmol) and acetic
acid (2.5 mL, 43.4 mol) in methanol (100 mL, N2 sparged) as
described previously for the preparation for 1a to give 852 mg
C